WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 6'4101 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 12'0691 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 31'377  30'973  30'565  30'159  29'760  25'915  21'827  17'359 
Births 615  617  618  618  616  624  660  627 
Surviving infants 604  606  607  606  605  604  620  570 
Pop. less than 5 years 3'020  3'011  2'993  2'973  2'958  3'009  3'009  2'753 
Pop. less than 15 years 8'753  8'727  8'694  8'660  8'635  8'903  8'406  7'342 
Female 15-49 years 8'310  8'230  8'147  8'062  7'970  6'758  5'421  4'054 

Number of reported cases

(Click for retrospective incidence data for Peru)
Diphtheria
ChartChart
  44  185 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  737  19'246 
Mumps
ChartChart
 
Pertussis
ChartChart
  119  236  1'373  1'173  56  68  1'134  12'134 
Polio*
ChartChart
  182 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
  10  93  294 
Tetanus (total)**
ChartChart
  22  21  35  17  38  57  124  525 
Yellow fever
ChartChart
  24  17  21  13  17  30 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Peru)
Vaccine year result method % card seen                                                
BCG 2012  93  DHS   79  91  94  95  95  91  93  83  57 
DTP1 2012  93  DHS   79  97  98  97  99*  94  91 
DTP3 2012  80  DHS   79  90  88  88  95  91  98  72  16 
DTP4          72  67 
IPV1          98  95 
HepB_BD          79  78  82  81  76  41 
HepB3 2012  80  DHS   79  90  88  88  95  91  44 
Hib3 2012  80  DHS   79  90  88  88  95  91  38 
JapEnc         
MCV1          92  89  85  94  96  64  23 
MCV2          63  44  54  63  70  97 
PCV1          98  99  97  99*  97 
PCV3          90  86  85  89  82 
Pol3 2012  84  DHS   79  88  78  71  94  91  93  73  16 
Rota1          95  96  95  98  90 
RotaC          87  86  86  91  84 
Rubella1          92  45  85  94  96 
TT2plus 2013  57  DHS   87  35  36  41  43  42 
PAB         
VAD1          94  99*  50 
YFV          67  65  64  58  51 
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Peru)
BCG
ChartChart
  94  95  95  91  93  83  57 
DTP1
ChartChart
  98  97  99  94  99  89  39 
DTP3
ChartChart
  88  88  95  91  98  72  16 
HepB3
ChartChart
  88  88  95  91 
HepB_BD
ChartChart
  78  82  81  76 
Hib3
ChartChart
  88  88  95  91  43 
MCV1
ChartChart
  89  85  94  96  97  64  23 
MCV2
ChartChart
  44  54  63  70 
PAB
ChartChart
  85  85  85  85  66  19 
PCV3
ChartChart
  86  85  89  82 
Pol3
ChartChart
  79  71  94  91  93  73  16 
RotaC
ChartChart
  86  86  91  84 
YFV
ChartChart
  65  64  58  51 

Number of districts in the country 1'838  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 32
From 80 to 89% 12
From 50 to 79% 34
Less than 50% 23
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 4, 6 months; Yes Risk groups (after reaction to the 1st dose of pentavalent)
DTwP 18 months; 4 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HPV 10 years; +2, +6 months; Yes
HepB_Adult > 5 years; +1, +1 months; Yes
HepB_Pediatric birth; Yes
IPV 2, 4 months; Yes
Influenza_Adult adults with chronic diseases, pregnant women, health care workers, and other risk groups
Influenza_Pediatric 6-23 months; Yes and children with chronic diseases
MMR 12, 18 months; Yes
OPV 6, 18 months; 4 years Yes
Pneumo_conj 2. 4, 12 months; Yes
Rotavirus 2, 4 months; Yes
Td 10 years; +2, +6 months; Yes CBAW and pregnant women
YF 15 months; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  No  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2015-2019      2011-2015  2006-2010 y 2011-2015  2007-2012  2008 - 2012 
Nº of districts with microplans that include activities to raise immunization coverage number 1'838      1'834  1'834  1'834  1'833 

System performance

Total Nº districts in country number 1'838  1'838  1'838  1'834  1'834  1'834  1'833 
Nº districts with DTP3 coverage >=80% number 813  774  886  862  951  992  1'391 
% of districts with DTP3 coverage >=80% From 0 to 100% 44  42  48  47  52  54  76 
Nº districts with measles (MCV1) coverage >=95% number 544  501  596  658  726  613  806 
% of districts with MCV1 coverage >=95% From 0 to 100% 30  27  32  36  40  33  44 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100  100  98  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.